Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine Extended-Release in Stable Angina (Phase II, China)
CTR20131950Phase 2Active
- Sponsor
- Furikangzheng Medical Technology
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in angina pectoris, sponsored by Furikangzheng Medical Technology. Started Feb 2014; status: active.
02
Drugs
ranolazine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on CTR20131950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131950.